Your browser doesn't support javascript.
loading
Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective Study.
Soma, Tomomi; Fujii, Kentaro; Yoshifuji, Ayumi; Maruki, Taketomo; Itoh, Kazuto; Taniyama, Daisuke; Kikuchi, Takahide; Hasegawa, Naoki; Nakamura, Morio.
Afiliación
  • Soma T; Department of Nephrology, Japan Community Health care Organization Saitama Medical Center, Japan.
  • Fujii K; Department of Nephrology, Tokyo Saiseikai Central Hospital, Japan.
  • Yoshifuji A; Department of Nephrology, Tokyo Saiseikai Central Hospital, Japan.
  • Maruki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
  • Itoh K; Department of General Internal Medicine, Tokyo Saiseikai Central Hospital, Japan.
  • Taniyama D; Department of Infectious Disease, Showa General Hospital, Japan.
  • Kikuchi T; Department of Hematology, Tokyo Saiseikai Central Hospital, Japan.
  • Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Nakamura M; Department of Pulmonary Medicine, National Hospital Organization Kanagawa Hospital, Japan.
Jpn J Infect Dis ; 75(5): 484-489, 2022 Sep 22.
Article en En | MEDLINE | ID: mdl-35491224
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hiperpotasemia Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Jpn J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hiperpotasemia Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Jpn J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article